BL-EI001

SI-6433

BL-EI001, >98% (HPLC)

IUPAC Name : 2-((1-(3,5-Dichlorophenyl)-2-(1H-imidazol-1-yl)ethoxy)methyl)benzo[d]thiazole

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : BL‑EI001 is a potent MEK/ERK pathway inhibitor with strong activity in triple‑negative breast cancer (TNBC) models. By blocking MEK‑dependent ERK phosphorylation, BL‑EI001 suppresses TNBC cell proliferation, migration, and survival, making it a valuable tool compound for studying MAPK‑driven TNBC biology and evaluating MEK/ERK‑targeted therapeutic strategies.

References : Liao M. et al.: J. Med. Chem., 64(5), 2382-2418, 2021.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.